ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.00%
US Dollar vs AUD
1.53139
0.00%
Bitcoin
63,549.38
0.22%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT
  6. Sanofi (SANF)

  7. Sanofi (SANF) News

SANF Sanofi

0.00
0.00 (0.00%)
- - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Sanofi SANF Italy Ordinary Share
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% -
Open Price Low Price High Price Close Price Previous Close
more quote information »

Recent News

Date Time Source Heading
25/4/202415:30GLOBEPress Release: Sanofi Q1: robust 7% sales growth driven by..
23/4/202415:00GLOBEPress Release: Rilzabrutinib LUNA 3 phase 3 study met..
17/4/202415:00GLOBEPress Release: New 48-week frexalimab phase 2 data support..
13/4/202404:05GLOBESanofi: Information concerning the total number of voting..
09/4/202402:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
22/3/202417:30GLOBEPress Release: Availability of the Q1 2024 Memorandum for..
16/3/202406:04GLOBESanofi: Informations relatives au nombre de droits de vote..
11/3/202417:00GLOBECommuniqué de presse : De nouveaux résultats de phase II..
25/2/202401:51GLOBEPress Release: Phase 2 results demonstrate rilzabrutinib..
24/2/202404:45GLOBEPress Release: Filing of the 2023 U.S. Form 20-F and French..
23/2/202417:00GLOBEPress Release: Dupixent® sBLA accepted for FDA Priority..
23/2/202405:02GLOBECommuniqué de presse : Le Conseil d’administration de Sanofi..
21/2/202409:40GLOBESanofi: Informations relatives au nombre de droits de vote..
16/2/202417:00GLOBECommuniqué de presse : Le Japon est le premier pays dans le..
16/2/202400:00GLOBECommuniqué de presse : Des données de phase II publiées dans..
05/2/202418:00GLOBEPress Release: Peer support, flexible work arrangements,..
01/2/202417:30GLOBEPress Release: Sanofi Delivers Solid Sales and Business EPS..
26/1/202406:30GLOBECommuniqué de presse : Dupixent® : premier et seul..
23/1/202417:30GLOBECommuniqué de presse : Sanofi va acquérir Inhibrx, Inc. et..
18/1/202408:57GLOBESanofi: Information concerning the total number of voting..
09/1/202417:30GLOBEPress Release: Brian Foard appointed Head of Specialty Care..
21/12/202317:30GLOBEPress Release: Sanofi announces end of program evaluating..
19/12/202307:59GLOBESanofi: Information concerning the total number of voting..
15/12/202317:30GLOBEPress Release: Availability of the Q4 2023 Memorandum for..
15/12/202317:00GLOBECommuniqué de presse : L’EMA a rendu un avis favorable pour..
12/12/202308:08GLOBECommuniqué de presse : Déclaration au sujet de la..
11/12/202311:30GLOBECP : Sarclisa® (isatuximab) plus KRd améliore..
07/12/202317:35GLOBECP : L’essai de phase III consacré au Sarclisa® (isatuximab)..
07/12/202313:30GLOBEPress Release: Sanofi Pipeline Transformation to Accelerate..
27/11/202317:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
24/11/202304:00GLOBESanofi: Information concerning the total number of voting..
27/10/202316:31GLOBECommuniqué de presse : Un troisième trimestre solide, marqué..
27/10/202316:30GLOBECommuniqué de presse : Sanofi entame un nouveau chapitre de..
23/10/202306:00GLOBEPress Release: Dupixent® (dupilumab) Phase 3 Results show..
19/10/202321:00GLOBECommuniqué de presse : Sanofi livre les premiers médicaments..
18/10/202319:45GLOBECommuniqué de presse : Des données de ph III présentées au..
18/10/202305:18GLOBESanofi: Informations relatives au nombre de droits de vote..
14/10/202301:00GLOBECommuniqué de presse : Des données de phase IIb de dernière..
04/10/202316:00GLOBECommuniqué de presse : Sanofi et Teva annoncent une..
03/10/202316:30GLOBECommuniqué de presse : Sanofi annonce un accord sur un..
26/9/202315:30GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
25/9/202317:00GLOBEPress Release: Once-weekly ALTUVIIIO® approved in Japan as a..
22/9/202315:30GLOBEPress Release: Availability of the Q3 2023 Memorandum for..
19/9/202316:30GLOBECommuniqué de presse : Sanofi soutient les communautés..
12/9/202304:02GLOBESanofi: Information concerning the total number of voting..
31/8/202315:30GLOBEPress Release: Sanofi announces changes to its Executive..
16/8/202305:24GLOBESanofi: Information concerning the total number of voting..
04/8/202305:21GLOBEPress Release: U.S. CDC Advisory Committee unanimously..
28/7/202321:22GLOBEPress release: Online availability of Sanofi’s half-year..
28/7/202315:32GLOBEPress Release: Sanofi to acquire Qunol®, a fast-growing U.S...

Your Recent History

BIT
SANF
Sanofi
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved